These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 34367883)

  • 1. Recent Advances in the Development of Theranostic Nanoparticles for Cardiovascular Diseases.
    Wu Y; Vazquez-Prada KX; Liu Y; Whittaker AK; Zhang R; Ta HT
    Nanotheranostics; 2021; 5(4):499-514. PubMed ID: 34367883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases.
    Sahoo RK; Singh H; Thakur K; Gupta U; Goyal AK
    Curr Pharm Des; 2022; 28(2):91-103. PubMed ID: 34218771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches.
    Bejarano J; Navarro-Marquez M; Morales-Zavala F; Morales JO; Garcia-Carvajal I; Araya-Fuentes E; Flores Y; Verdejo HE; Castro PF; Lavandero S; Kogan MJ
    Theranostics; 2018; 8(17):4710-4732. PubMed ID: 30279733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases.
    Kim KS; Song CG; Kang PM
    Antioxid Redox Signal; 2019 Feb; 30(5):733-746. PubMed ID: 29228781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle: A Promising Player in Nanomedicine and its Theranostic Applications for the Treatment of Cardiovascular Diseases.
    Saeed S; Ud Din SR; Khan SU; Gul R; Kiani FA; Wahab A; Zhong M
    Curr Probl Cardiol; 2023 May; 48(5):101599. PubMed ID: 36681209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel cutting edge nano-strategies to address old long-standing complications in cardiovascular diseases. A comprehensive review.
    Tesoro L; Hernandez I; Saura M; Badimón L; Zaragoza C
    Eur J Clin Invest; 2024 Jul; 54(7):e14208. PubMed ID: 38622800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle theranostics in cardiovascular inflammation.
    MacRitchie N; Di Francesco V; Ferreira MFMM; Guzik TJ; Decuzzi P; Maffia P
    Semin Immunol; 2021 Aug; 56():101536. PubMed ID: 34862118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Atherosclerosis Theranostics Harnessing Iron Oxide-Based Nanoparticles.
    Wang S; He H; Mao Y; Zhang Y; Gu N
    Adv Sci (Weinh); 2024 May; 11(17):e2308298. PubMed ID: 38368274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles in endothelial theranostics.
    Zapotoczny S; Szczubialka K; Nowakowska M
    Pharmacol Rep; 2015 Aug; 67(4):751-5. PubMed ID: 26321277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional theranostic nanoparticles for biomedical cancer treatments - A comprehensive review.
    Kandasamy G; Maity D
    Mater Sci Eng C Mater Biol Appl; 2021 Aug; 127():112199. PubMed ID: 34225852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in nanobased platforms for cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering.
    Shariati L; Esmaeili Y; Rahimmanesh I; Babolmorad S; Ziaei G; Hasan A; Boshtam M; Makvandi P
    Environ Res; 2023 Dec; 238(Pt 1):116933. PubMed ID: 37652218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A biocompatible theranostic agent based on stable bismuth nanoparticles for X-ray computed tomography/magnetic resonance imaging-guided enhanced chemo/photothermal/chemodynamic therapy for tumours.
    Zhao H; Wang J; Li X; Li Y; Li C; Wang X; Wang J; Guan S; Xu Y; Deng G; Chen Y; Lu J; Liu X
    J Colloid Interface Sci; 2021 Dec; 604():80-90. PubMed ID: 34265694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Functionalization of the NIR-Responsive Photothermal Semiconductor Nanomaterials for Cancer Theranostics.
    Huang X; Zhang W; Guan G; Song G; Zou R; Hu J
    Acc Chem Res; 2017 Oct; 50(10):2529-2538. PubMed ID: 28972736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent.
    Chang LH; Chuang EY; Cheng TM; Lin C; Shih CM; Wu AT; Jheng PR; Lu HY; Shih CC; Mi FL
    Acta Biomater; 2021 Oct; 134():686-701. PubMed ID: 34358695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polydopamine coated multifunctional lanthanide theranostic agent for vascular malformation and tumor vessel imaging beyond 1500 nm and imaging-guided photothermal therapy.
    Li X; Jiang M; Zeng S; Liu H
    Theranostics; 2019; 9(13):3866-3878. PubMed ID: 31281519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomaterials as Novel Cardiovascular Theranostics.
    Pala R; Pattnaik S; Busi S; Nauli SM
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33799932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine Approaches for Advanced Diagnosis and Treatment of Atherosclerosis and Related Ischemic Diseases.
    Hu B; Boakye-Yiadom KO; Yu W; Yuan ZW; Ho W; Xu X; Zhang XQ
    Adv Healthc Mater; 2020 Aug; 9(16):e2000336. PubMed ID: 32597562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsically Mn2+-Chelated Polydopamine Nanoparticles for Simultaneous Magnetic Resonance Imaging and Photothermal Ablation of Cancer Cells.
    Miao ZH; Wang H; Yang H; Li ZL; Zhen L; Xu CY
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):16946-52. PubMed ID: 26196160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities.
    Yang P; Ren J; Yang L
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.